Synthetic Genomics said this week that it has purchased from Febit Holding GmbH the worldwide rights to three families of patents and patent applications related to gene synthesis.

As part of the deal, La Jolla, Calif.-based SGI also acquired all related know-how, equipment and technical support for the implementation of the technology, the firm said. Terms of the agreement were not discussed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.